Acetylcholine Receptor Antibody Titer and HLA-B8 Antigen in Myasthenia Gravis
Authors:
- John KeeseyJKJohn Keesey
- Faramarz NaiemFNFaramarz Naiem
- Jon LindstromJLJon Lindstrom
- Denise RoeDRDenise Roe
- Christian HerrmannCHChristian Herrmann
- Roy WalfordRWRoy Walford
- 1 February 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 39 (2) , 73-77
Abstract
• In 82 white patients with myasthenia gravis, a high serum human acetylcholine receptor (AChR) antibody titer was related to the presence of the HLA-B8 antigen and increasing severity of the disease and not to age at onset, sex, presence of thymoma, or mode of treatment. Among patients without thymomas a high antibody titer was also associated with HLA-B8, particularly in those patients whose age at onset was less than 35 years. Thymectomy was associated with a lower median antibody titer when compared in two groups of HLA-B8-positive patients without thymoma who were similar for all other factors. Patients with thymomas who had received corticosteroids had a lower median titer than those who had not received steroids. This study supports the possibility that immune-response genes near the HLA-B8 segment of the major histocompatibility complex participate in the regulation of the humoral response to autoantigens, such as AChR protein.Keywords
This publication has 5 references indexed in Scilit:
- HLA and neurologic diseaseNeurology, 1978
- An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravisClinical Immunology and Immunopathology, 1977
- Genetic associations between myasthenia gravis and the HL-A system.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- Acetylcholine Receptor Antibodies in Myasthenia GravisNew England Journal of Medicine, 1975
- HL‐A Frequencies in Patients with Myasthenia GravisTissue Antigens, 1973